KAISER WESTSIDE MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.6M
- Transactions
- 94
- Companies
- 12
- Average per transaction
- $17,496
Who reported the payments
| Janssen Scientific Affairs, LLC | $506,646 |
| Karyopharm Therapeutics Inc. | $274,931 |
| Purdue Pharma L.p. | $252,955 |
| Takeda Pharmaceuticals U.S.A., Inc. | $177,531 |
| Eli Lilly | $131,945 |
| AstraZeneca | $127,443 |
| E.r. Squibb & Sons, L.L.C. | $77,999 |
| Janssen Research & Development, LLC | $29,458 |
| Intercept Pharmaceuticals, Inc. | $24,281 |
| EMD Serono, Inc. | $19,094 |
| Nuwellis, Inc. | $18,082 |
| Merck | $4,247 |